The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy
Open accessAbstract
After several decades of continuously successful antibiotic therapy against bacterial infections, we are now facing a worrying prospect: the accelerated evolution of antibiotic resistance to important human pathogens and the scarcity of new anti-infective drug families under development. Efflux is a general mechanism responsible for bacterial resistance to antibiotics. This active drug transport is involved in low intrinsic susceptibility, cross-resistance to chemically unrelated classes of molecules, and selection/acquisition of additional mechanisms of resistance. Thus, inhibition of bacterial efflux mechanisms appears to be a promising target in order to (i) increase the intracellular concentration of antibiotics that are expelled by efflux pumps, (ii) restore the drug susceptibility of resistant clinical strains, and (iii) reduce the capability for acquired additional resistance. Structurally unrelated classes of efflux pump inhibitors (EPIs) have been described and tested in the last decade, including some analogues of antibiotic substrates and new chemical molecules. Among the current collection of EPIs, only a few compounds have been studied taking into account the structure-activity relationships and the spectrum of activity in terms of antibiotics, pumps and bacteria. While large efforts have characterized an increasing number of bacterial efflux pumps and generated several potentially active EPIs, they have not elucidated the molecular basis of efflux transport and inhibition. Recent studies of pump-substrate complexes, the 3D resolution of the efflux pumps, the synthesis of novel compounds and molecular dynamic studies may generate new clues to decipher and select novel targets inside the efflux mechanisms and, finally, may result in a clinically useful molecule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M.-T., Godoy, P., Ramos-González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 791
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 773
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism
Seeger, M. A., Schiefner, A., Eicher, T., Verrey, F., Diederichs, K., & Pos, K. M. (2006) · Science · doi:10.1126/science.1131542 · Cited by 590
Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials
Tegos, G., Stermitz, F. R., Lomovskaya, O., & Lewis, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3133-3141.2002 · Cited by 517
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
Lomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 460
Regulation of bacterial drug export systems
Grkovic, S., Brown, M. H., & Skurray, R. A. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.4.671-701.2002 · Cited by 423
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401
Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump
Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H., & Koshland, D. E. (2003) · Science · doi:10.1126/science.1083137 · Cited by 392
Nishino, K., Latifi, T., & Groisman, E. A. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04940.x · Cited by 385
Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Yu, E. W., Aires, J. R., McDermott, G., & Nikaido, H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6804-6815.2005 · Cited by 242
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J.-M., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 238
Self-citationBohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Self-citationMultidrug efflux pumps and resistance: regulation and evolution
Paulsen, I. T. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.005 · Cited by 220
Van Bambeke, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg224 · Cited by 203
Mallea, M., Chevalier, J., Bornet, C., Eyraud, A., Davin-Regli, A., Bollet, C., & Pages, J.-M. (1998) · Microbiology · doi:10.1099/00221287-144-11-3003 · Cited by 177
Self-citationMahamoud, A., Chevalier, J., Davin-Regli, A., Barbe, J., & Pages, J.-M. (2006) · Current Drug Targets · doi:10.2174/138945006777709557 · Cited by 177
Self-citationKern, W. V., Steinke, P., Schumacher, A., Schuster, S., Baum, H. V., & Bohnert, J. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki445 · Cited by 172
Self-citationBambeke, F., Pages, J.-M., & Lee, V. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452692 · Cited by 171
Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl081 · Cited by 168
Self-citationTsubery, H., Ofek, I., Cohen, S., & Fridkin, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0000057 · Cited by 167
Three's company: component structures bring a closer view of tripartite drug efflux pumps
Eswaran, J., Koronakis, E., Higgins, M. K., Hughes, C., & Koronakis, V. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.10.003 · Cited by 162
Tracing pathways of transport protein evolution
Saier, M. H. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03499.x · Cited by 159
Kriengkauykiat, J., Porter, E. M., Lomovskaya, O., & Wong‐Beringer, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.565-570.2005 · Cited by 137
Ricci, V., Tzakas, P., Buckley, A. M., Coldham, N. G., & Piddock, L. J. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.38-42.2006 · Cited by 131
Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D., & Kern, W. V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki446 · Cited by 126
Self-citationIn search of natural substrates and inhibitors of MDR pumps.
Lewis, K. (2001) · PubMed · Cited by 126
Antimicrobial activity of phenothiazines.
Amaral, L., Viveiros, M., & Molnar, J. A. (2004) · PubMed · Cited by 121
TolC – the bacterial exit duct for proteins and drugs
Koronakis, V. E. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01125-6 · Cited by 120
Malléa, M., Mahamoud, A., Chevalier, J., Alibert, S., Brouant, P., Barbe, J., & Pagès, J. (2003) · Biochemical Journal · doi:10.1042/bj20030963 · Cited by 117
Self-citationYan, M., Şahin, O., Lin, J., & Zhang, Q. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl412 · Cited by 105
Chevalier, J., Bredin, J., Mahamoud, A., Malléa, M., Barbe, J., & Pagès, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1043-1046.2004 · Cited by 104
Self-citationRenau, T. E., Léger, R., FILONOVA, L. K., Flamme, E. M., Wang, M., Yen, R., Madsen, D., Griffith, D. E., Chamberland, S., Dudley, M. N., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00556-0 · Cited by 98
Nelson, M. L., & Levy, S. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1719 · Cited by 96
Kaatz, G. W. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00220-6 · Cited by 93
Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Hosono, S., Ohta, T., Hoshino, K., Ishida, H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.024 · Cited by 86
Chevalier, J., Atifi, S., Eyraud, A., Mahamoud, A., Barbe, J., & Pagès, J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010911z · Cited by 85
Self-citationRenau, T. E., Léger, R., Yen, R., She, M. W., Flamme, E. M., Sangalang, J. C., Gannon, C. L., Chamberland, S., Lomovskaya, O., & LEE, V. J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00006-9 · Cited by 78
Watkins, W. J., Landaverry, Y. R., Léger, R., Litman, R., Renau, T. E., Williams, N., Yen, R., Zhang, J. Z., Chamberland, S., Madsen, D., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.030 · Cited by 78
Nelson, M. L., Park, B. H., Andrews, J. S., Georgian, V. A., Thomas, R. C., & Levy, S. B. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00055a008 · Cited by 71
Nakayama, K., Kawato, H. C., Watanabe, J., Ohtsuka, M., Yoshida, K., Yokomizo, Y., Sakamoto, A., Kuru, N., Ohta, T., Hoshino, K., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.060 · Cited by 66
Bacterial efflux pump inhibition.
Kaatz, G. W. (2005) · PubMed · Cited by 64
Yoshida, K., Nakayama, K., Yokomizo, Y., Ohtsuka, M., Takemura, M., Hoshino, K., Kanda, H., Namba, K., Nitanai, H., Zhang, J. Z., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.037 · Cited by 62
Nelson, M. L., Park, B. H., & Levy, S. B. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a016 · Cited by 62
Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H. C., Yoshida, K., Yokomizo, Y., Ohta, T., Hoshino, K., Otani, T., Kurosaka, Y., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.027 · Cited by 59
3-Arylpiperidines as potentiators of existing antibacterial agents
Thorarensen, A., Presley, A. L., Marotti, K. R., Boyle, T. P., Heckaman, C. L., Bohanon, M. J., Tomich, P. K., Zurenko, G. E., Sweeney, M. T., & Yagi, B. H. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00330-4 · Cited by 57
Nakayama, K., Kuru, N., Ohtsuka, M., Yokomizo, Y., Sakamoto, A., Kawato, H. C., Yoshida, K., Ohta, T., Hoshino, K., Akimoto, K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.007 · Cited by 51
Yoshida, K., Nakayama, K., Kuru, N., Kobayashi, S., Ohtsuka, M., Takemura, M., Hoshino, K., Kanda, H., Zhang, J. Z., LEE, V. J., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.10.043 · Cited by 49
Dean, C. R., Narayan, S., Daigle, D. M., Dzink-Fox, J., Puyang, X., Bracken, K. R., Dean, K., Weidmann, B., Yuan, Z., Jain, R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3129-3135.2005 · Cited by 47
Ghisalberti, D., Mahamoud, A., Chevalier, J., Baitiche, M., de Martino, M., Pagès, J., & Barbe, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.010 · Cited by 39
Self-citationGallo, S. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00215-2 · Cited by 35
Tsubery, H., Yaakov, H., Cohen, S., Giterman, T., Matityahou, A., Fridkin, M., & Ofek, I. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3122-3128.2005 · Cited by 35
The ins and outs of drug transport
Schuldiner, S. (2006) · Nature · doi:10.1038/443156b · Cited by 30
Role of Bacterial Porins in Antibiotic Susceptibility of Gram‐Negative Bacteria
Pagès, J. (2004) · doi:10.1002/3527603875.ch3 · Cited by 19
Self-citationElkins, C. A., & Beenken, K. E. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.6.581 · Cited by 7
Cited by
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Plants as sources of new antimicrobials and resistance-modifying agents
Abreu, A. C., McBain, A. J., & Simões, M. (2012) · Natural Product Reports · doi:10.1039/c2np20035j · Cited by 519
Metadata
- Authors
- Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., & Pagès, J.-M.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-17
- Volume
- 59
- Issue
- 6
- Pages
- 1223-1229
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2119306581
- Cited by
- 270
- References
- 64
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.